DIN 02565277 — LIVMARLI 19 MG
LIVMARLI is a solution of Maralixibat marketed by MIRUM PHARMACEUTICALS, INC.. The full Maralixibat monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02565277
- Brand name
- LIVMARLI
- Active ingredient
- Maralixibat
- Strength
- 19 MG
- Dosage form
- SOLUTION
- Route
- ORAL
- Manufacturer
- MIRUM PHARMACEUTICALS, INC.
- Health Canada status
- MARKETED
- Drug class
- Ileal bile acid transporter (IBAT) inhibitor
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Maralixibat products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02565234 | LIVMARLI | 10 MG | TABLET | MIRUM PHARMACEUTICALS, INC. | MARKETED |
| 02565242 | LIVMARLI | 15 MG | TABLET | MIRUM PHARMACEUTICALS, INC. | MARKETED |
| 02565250 | LIVMARLI | 20 MG | TABLET | MIRUM PHARMACEUTICALS, INC. | MARKETED |
| 02565269 | LIVMARLI | 30 MG | TABLET | MIRUM PHARMACEUTICALS, INC. | MARKETED |
| 02539888 | LIVMARLI | 9.5 MG | SOLUTION | MIRUM PHARMACEUTICALS, INC. | MARKETED |